Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malato

Showing results (241-250 of 274) with videos related to

Pageof 28
Sort By:
Scientific Reports|August 26, 2018
Publisher Correction: Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophyKenneth J Katschke, Hongkang Xi, Christian Cox, et al.
Annals of Hematology|December 14, 2019
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practiceMassimo Breccia, Claudia Baratè, Giulia Benevolo, et al.
British Journal of Haematology|May 21, 2019
Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study)Elena M Elli, Alessandra Iurlo, Andrea Aroldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2025
ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway TrialFunda Meric-Bernstam, Kanwal Pratap Singh Raghav, Christopher J Sweeney, et al.
The Science of the Total Environment|December 23, 2018
Consolidated vs new advanced treatment methods for the removal of contaminants of emerging concern from urban wastewaterLuigi Rizzo, Sixto Malato, Demet Antakyali, et al.
Hepatology (Baltimore, Md.)|August 19, 2014
A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liverAras N Mattis, Guisheng Song, Kelly Hitchner, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2020
Clinical history of cancer-associated splanchnic vein thrombosisEmanuele Valeriani, Marcello Di Nisio, Nicoletta Riva, et al.
ESMO Open|May 27, 2026
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathwayY Matsubara, M Wakabayashi, W Okamoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid TumorsChristopher J Sweeney, John D Hainsworth, Ron Bose, et al.
American Journal of Hematology|September 29, 2011
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS studySergio Siragusa, Alessandra Malato, Giorgia Saccullo, et al.
Pageof 28

Showing results (241-250 of 274) with videos related to

Sort By:
Pageof 28
Scientific Reports|August 26, 2018
Publisher Correction: Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophyKenneth J Katschke, Hongkang Xi, Christian Cox, et al.
Annals of Hematology|December 14, 2019
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practiceMassimo Breccia, Claudia Baratè, Giulia Benevolo, et al.
British Journal of Haematology|May 21, 2019
Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study)Elena M Elli, Alessandra Iurlo, Andrea Aroldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2025
ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway TrialFunda Meric-Bernstam, Kanwal Pratap Singh Raghav, Christopher J Sweeney, et al.
The Science of the Total Environment|December 23, 2018
Consolidated vs new advanced treatment methods for the removal of contaminants of emerging concern from urban wastewaterLuigi Rizzo, Sixto Malato, Demet Antakyali, et al.
Hepatology (Baltimore, Md.)|August 19, 2014
A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liverAras N Mattis, Guisheng Song, Kelly Hitchner, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2020
Clinical history of cancer-associated splanchnic vein thrombosisEmanuele Valeriani, Marcello Di Nisio, Nicoletta Riva, et al.
ESMO Open|May 27, 2026
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathwayY Matsubara, M Wakabayashi, W Okamoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid TumorsChristopher J Sweeney, John D Hainsworth, Ron Bose, et al.
American Journal of Hematology|September 29, 2011
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS studySergio Siragusa, Alessandra Malato, Giorgia Saccullo, et al.
Pageof 28